TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Multicenter, Randomized, Double-Blind, Active and Placebo-Controlled 24-Week Study Followed by Long Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in Biologic Disease-Modifying Antirheumatic Drug-Naive Patients With Active Psoriatic Arthritis
Brief Summary: This study will assess the safety and efficacy of ixekizumab (LY2439821) compared to placebo in participants with active psoriatic arthritis.


Options:
A: Arm Label: Etanercept 50 mg; Type: EXPERIMENTAL; Interventions: Drug: Etanercept | Intervention Type: DRUG; Name: Etanercept; Assigned to Arm(s): Etanercept 50 mg
B: Arm Label: Etanercept; Type: EXPERIMENTAL; Interventions: Drug: Etanercept | Intervention Type: DRUG; Name: Etanercept; Assigned to Arm(s): Etanercept
C: Arm Label: Ixekizumab Q2W; Type: EXPERIMENTAL; Interventions: Drug: Ixekizumab | Arm Label: Ixekizumab Q4W; Type: EXPERIMENTAL; Interventions: Drug: Ixekizumab | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Adalimumab Q2W; Type: ACTIVE_COMPARATOR; Interventions: Drug: Adalimumab | Intervention Type: DRUG; Name: Ixekizumab; Assigned to Arm(s): Ixekizumab Q2W, Ixekizumab Q4W | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: Adalimumab; Assigned to Arm(s): Adalimumab Q2W
D: Arm Label: Therapeutic drug monitoring; Type: EXPERIMENTAL; Interventions: Other: Therapeutic drug monitoring | Arm Label: Standard care; Type: ACTIVE_COMPARATOR; Interventions: Other: Standard care | Intervention Type: OTHER; Name: Therapeutic drug monitoring; Assigned to Arm(s): Therapeutic drug monitoring | Intervention Type: OTHER; Name: Standard care; Assigned to Arm(s): Standard care

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Soft-hard Technologies to Assistance and Accessibility in Patients With Chronic Diseases: The Effect of a Five Week Electrical Myostimulation Program.
Brief Summary: Patients afflicted with Chronic Heart Failure (HF) typically do not maintain stable cardiac function for the remainder of their life and consequently require continuous medical management and intermittent hospital admissions. Several investigations have demonstrated that electrical muscle stimulation (EMS) produces positive physiologic and psychological adaptations in patients with HF. However not all the EMS modalities were been evaluated on this population or not even were tested based on present recognized gold standard clinical parameters after a short period of treatment. The primary aims of the proposed study is to: Determine the effect of a five week home based of three EMS modalities on prognostics markers, perceived quality of life, muscle force and electrical activity in subjects diagnosed with HF.


Options:
A: Arm Label: NMES group; Type: EXPERIMENTAL; Interventions: Other: Neuromuscular electrical stimulation, Other: Endurance training, Other: Quadriceps strength training | Arm Label: Control group; Type: SHAM_COMPARATOR; Interventions: Other: Endurance training, Other: Quadriceps strength training | Intervention Type: OTHER; Name: Neuromuscular electrical stimulation; Assigned to Arm(s): NMES group | Intervention Type: OTHER; Name: Endurance training; Assigned to Arm(s): Control group, NMES group | Intervention Type: OTHER; Name: Quadriceps strength training; Assigned to Arm(s): Control group, NMES group
B: Arm Label: Functional electrical stimulation; Type: EXPERIMENTAL; Interventions: Procedure: Functional electrical stimulation | Arm Label: Medium-frequency alternating current; Type: EXPERIMENTAL; Interventions: Procedure: Medium-frequency alternating current | Arm Label: Burst-modulated alternating current; Type: EXPERIMENTAL; Interventions: Procedure: Burst-modulated alternating current | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Procedure: Placebo | Intervention Type: PROCEDURE; Name: Medium-frequency alternating current; Assigned to Arm(s): Medium-frequency alternating current | Intervention Type: PROCEDURE; Name: Burst-modulated alternating current; Assigned to Arm(s): Burst-modulated alternating current | Intervention Type: PROCEDURE; Name: Placebo; Assigned to Arm(s): Placebo | Intervention Type: PROCEDURE; Name: Functional electrical stimulation; Assigned to Arm(s): Functional electrical stimulation
C: Arm Label: ES; Type: ACTIVE_COMPARATOR; Interventions: Device: Electrostimulation | Arm Label: Sham ES; Type: PLACEBO_COMPARATOR; Interventions: Device: Sham stimulation | Intervention Type: DEVICE; Name: Electrostimulation; Assigned to Arm(s): ES | Intervention Type: DEVICE; Name: Sham stimulation; Assigned to Arm(s): Sham ES
D: Intervention Type: DEVICE; Name: Neuromuscular Electrical stimulator (Cefar rehab 4 pro); Assigned to Arm(s): N/A

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomised Controlled Trail of Duct-to-mucosa Versus Invagination for Pancreaticojejunostomy After Pancreaticoduodenectomy
Brief Summary: The purpose of this study is to determine whether duct-to-mucosa is better than invagination in pancreaticojejunostomy after pancreaticoduodenectomy. This single-centre, open, randomized controlled trail is conducted following ISGPF criteria for pancreatic fistula (PF). The duration of the study is supposed to start from Jan 5th 2012 and last to Dec 2014, until 100 or more cases are accessible. Patients diagnosed with pancreatic cancer, peri-ampullar carcinoma or other benign or malignant diseases which need to operate pancreaticoduodenectomy will be included. Main outcomes are pancreatic fistula rate, mortality, morbidity, reoperation and hospital stay. The investigators assumption that duct-to-mucosa is better than invagination.


Options:
A: Arm Label: One-layer duct-to-mucosa Group; Type: EXPERIMENTAL; Interventions: Procedure: Modified one-layer duct-to-mucosa Pancreaticojejunostomy | Arm Label: Invagination Group; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Invagination pancreaticojejunostomy | Intervention Type: PROCEDURE; Name: Modified one-layer duct-to-mucosa Pancreaticojejunostomy; Assigned to Arm(s): One-layer duct-to-mucosa Group | Intervention Type: PROCEDURE; Name: Invagination pancreaticojejunostomy; Assigned to Arm(s): Invagination Group
B: Arm Label: duct-to-mucosa; Type: EXPERIMENTAL; Interventions: Procedure: duct-to-mucosa, Device: Internal stent | Arm Label: invagination; Type: ACTIVE_COMPARATOR; Interventions: Procedure: invagination, Device: Internal stent | Intervention Type: PROCEDURE; Name: duct-to-mucosa; Assigned to Arm(s): duct-to-mucosa | Intervention Type: PROCEDURE; Name: invagination; Assigned to Arm(s): invagination | Intervention Type: DEVICE; Name: Internal stent; Assigned to Arm(s): duct-to-mucosa, invagination
C: Arm Label: Duct to mucosa PJ group; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Duct to mucosa PJ group | Arm Label: Invagination PJ group; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Invagination PJ group | Intervention Type: PROCEDURE; Name: Duct to mucosa PJ group; Assigned to Arm(s): Duct to mucosa PJ group | Intervention Type: PROCEDURE; Name: Invagination PJ group; Assigned to Arm(s): Invagination PJ group
D: Arm Label: horizontal mattress; Type: EXPERIMENTAL; Interventions: Procedure: pancreaticojejunostomy with horizontal mattress suture | Arm Label: interrupted suture; Type: EXPERIMENTAL; Interventions: Procedure: pancreaticojejunostomy with interrupted suture | Intervention Type: PROCEDURE; Name: pancreaticojejunostomy with horizontal mattress suture; Assigned to Arm(s): horizontal mattress | Intervention Type: PROCEDURE; Name: pancreaticojejunostomy with interrupted suture; Assigned to Arm(s): interrupted suture

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized, Controlled, Open-Label, Phase 2 Trial of SGI-110 and Carboplatin in Subjects With Platinum-Resistant Recurrent Ovarian Cancer
Brief Summary: A 2-part, Phase 2 controlled, open-label, randomized study in participants with platinum-resistant recurrent ovarian cancer. In Part 1, participants received SGI-110 and carboplatin. The optimum dose of SGI-110 (guadecitabine) was identified in Part 1 based on safety and efficacy. In Part 2, participants were randomized to receive the dose identified in Part 1 plus carboplatin or one of four treatment of choice at the discretion of the investigator. The treatment of choice consisted of topotecan, pegylated liposomal doxorubicin, paclitaxel or gemcitabine.


Options:
A: Arm Label: Arm I; Type: EXPERIMENTAL; Interventions: Drug: docetaxel, Drug: vandetanib | Arm Label: Arm II; Type: EXPERIMENTAL; Interventions: Drug: docetaxel, Drug: vandetanib | Intervention Type: DRUG; Name: docetaxel; Assigned to Arm(s): Arm I, Arm II | Intervention Type: DRUG; Name: vandetanib; Assigned to Arm(s): Arm I, Arm II
B: Arm Label: Chemotherapy; Type: ACTIVE_COMPARATOR; Interventions: Drug: liposomal doxorubicin, Drug: paclitaxel, Drug: topotecan | Arm Label: Chemotherapy + Bevacizumab; Type: EXPERIMENTAL; Interventions: Drug: Bevacizumab, Drug: liposomal doxorubicin, Drug: paclitaxel, Drug: topotecan | Intervention Type: DRUG; Name: Bevacizumab; Assigned to Arm(s): Chemotherapy + Bevacizumab | Intervention Type: DRUG; Name: liposomal doxorubicin; Assigned to Arm(s): Chemotherapy, Chemotherapy + Bevacizumab | Intervention Type: DRUG; Name: paclitaxel; Assigned to Arm(s): Chemotherapy, Chemotherapy + Bevacizumab | Intervention Type: DRUG; Name: topotecan; Assigned to Arm(s): Chemotherapy, Chemotherapy + Bevacizumab
C: Arm Label: SGI-110 + Carboplatin; Type: EXPERIMENTAL; Interventions: Drug: SGI-110, Drug: Carboplatin | Arm Label: SGI-110 + Carboplatin or TC; Type: EXPERIMENTAL; Interventions: Drug: SGI-110, Drug: Treatment of Choice (topotecan, pegylated liposomal doxorubicin, paclitaxel, or gemcitabine), Drug: Carboplatin | Intervention Type: DRUG; Name: SGI-110; Assigned to Arm(s): SGI-110 + Carboplatin, SGI-110 + Carboplatin or TC | Intervention Type: DRUG; Name: Treatment of Choice (topotecan, pegylated liposomal doxorubicin, paclitaxel, or gemcitabine); Assigned to Arm(s): SGI-110 + Carboplatin or TC | Intervention Type: DRUG; Name: Carboplatin; Assigned to Arm(s): SGI-110 + Carboplatin, SGI-110 + Carboplatin or TC
D: Arm Label: Bevacizumab+TC; Type: EXPERIMENTAL; Interventions: Drug: Bevacizumab, Drug: TC:paclitaxel + carboplatin | Arm Label: TC; Type: ACTIVE_COMPARATOR; Interventions: Drug: TC:paclitaxel + carboplatin | Intervention Type: DRUG; Name: Bevacizumab; Assigned to Arm(s): Bevacizumab+TC | Intervention Type: DRUG; Name: TC:paclitaxel + carboplatin; Assigned to Arm(s): Bevacizumab+TC, TC

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effect of a Supervised Exercise Program During Whole Pregnancy on Outcomes and Level of Depression. A Randomized Controlled Trial
Brief Summary: Due to physical and physiological changes that occur in pregnant women, depression is very common during this period. Recent research findings indicate that antenatal maternal mood state impacts on babies health. Nowadays, many researchers are focussed on examining the effects of physical exercise on foetal and maternal outcomes.

The main aim of this study was to assess the effectiveness of a supervised exercise program consisted of 25-30 minutes of cardiovascular exercise,10 minutes of specific exercises (strength and balance exercises), and 10 minutes of pelvis floor muscles training, on the prevention and treatment of depression in pregnant women. Additionally, the other purpose of the study was to analyze the effects of depression and physical exercise on outcomes.

Hypothesis: Pregnant women who do regular exercise during their pregnancies would have a better mood state than pregnant women who are sedentary, without having any negative effect on outcomes.


Options:
A: Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Exercise group; Type: EXPERIMENTAL; Interventions: Behavioral: Exercise group | Intervention Type: BEHAVIORAL; Name: Exercise group; Assigned to Arm(s): Exercise group
B: Arm Label: Group 1; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Structured training and leaflet | Arm Label: Group 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Structured training | Arm Label: Group 3; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Leaflet | Arm Label: Group 4; Type: SHAM_COMPARATOR; Interventions: Behavioral: Control Group | Intervention Type: BEHAVIORAL; Name: Structured training and leaflet; Assigned to Arm(s): Group 1 | Intervention Type: BEHAVIORAL; Name: Structured training; Assigned to Arm(s): Group 2 | Intervention Type: BEHAVIORAL; Name: Leaflet; Assigned to Arm(s): Group 3 | Intervention Type: BEHAVIORAL; Name: Control Group; Assigned to Arm(s): Group 4
C: Arm Label: exercise; Type: EXPERIMENTAL; Interventions: Behavioral: specific training program | Arm Label: control; Type: ACTIVE_COMPARATOR; Interventions: Other: standard | Intervention Type: OTHER; Name: standard; Assigned to Arm(s): control | Intervention Type: BEHAVIORAL; Name: specific training program; Assigned to Arm(s): exercise
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Solifenacin succinate | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Behavioral: Simplified bladder training | Intervention Type: DRUG; Name: Solifenacin succinate; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Simplified bladder training; Assigned to Arm(s): 2

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Effect of Vitamin D on Measures of Bone Health and Gene Expression
Brief Summary: Vitamin D deficiency is now recognized as one of the most common vitamin deficiencies in adults in the United States. Vitamin D deficiency has been connected to many chronic health diseases. The goal of this innovative research is to identify how vitamin D is able to have such wide ranging health benefits. This study will determine which genes are turned on and turned off in adults who receive 2000 IU vitamin D3 per day compared to 400 IU vitamin D3 per day. Results should provide important new insights about the health benefits of vitamin D for adults.


Options:
A: Arm Label: Arm A; Type: N/A; Interventions: Dietary Supplement: 400 IU vitamin D3 | Arm Label: Arm B; Type: N/A; Interventions: Dietary Supplement: 2000 IU vitamin D3 | Intervention Type: DIETARY_SUPPLEMENT; Name: 400 IU vitamin D3; Assigned to Arm(s): Arm A | Intervention Type: DIETARY_SUPPLEMENT; Name: 2000 IU vitamin D3; Assigned to Arm(s): Arm B
B: Arm Label: Intervention Group; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Vitamin D | Arm Label: Control Group; Type: OTHER; Interventions: Dietary Supplement: Vitamin D | Intervention Type: DIETARY_SUPPLEMENT; Name: Vitamin D; Assigned to Arm(s): Control Group, Intervention Group
C: Arm Label: High-dose vitamin D; Type: EXPERIMENTAL; Interventions: Drug: High-dose vitamin D 3 | Arm Label: Conventional-dose vitamin D; Type: ACTIVE_COMPARATOR; Interventions: Drug: Conventional-Dose Vitamin D 3 | Intervention Type: DRUG; Name: High-dose vitamin D 3; Assigned to Arm(s): High-dose vitamin D | Intervention Type: DRUG; Name: Conventional-Dose Vitamin D 3; Assigned to Arm(s): Conventional-dose vitamin D
D: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: daily vitamin D supplement, Other: Placebo | Arm Label: Vitamin D; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Vitamin D, Dietary Supplement: daily vitamin D supplement | Intervention Type: DIETARY_SUPPLEMENT; Name: Vitamin D; Assigned to Arm(s): Vitamin D | Intervention Type: DIETARY_SUPPLEMENT; Name: daily vitamin D supplement; Assigned to Arm(s): Placebo, Vitamin D | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effectiveness of Combined Intervention Approaches in the Treatment of Affective Disorders and Chronic Pain in Victims of Torture and Massive Violence in Kosovo: A Randomized Controlled Trial
Brief Summary: This study will measure the effects of biofeedback supported cognitive behavioral therapy (BF-CBT) and group physiotherapy intervention in victims of torture and massive violence in Kosovo. The investigators aim to restore physical and psychosocial functioning of the victims of torture and massive violence with available rehabilitation practice and integrate them into the community. It is also our objective to build local knowledge and expertise to apply measurement principles and CBT methods in the Balkan region.


Options:
A: Arm Label: 1 Interpersonal Psychotherapy (IPT); Type: EXPERIMENTAL; Interventions: Behavioral: Interpersonal Psychotherapy | Arm Label: 2 Prolonged Exposure (PE); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Prolonged Exposure Therapy | Arm Label: 3 Relaxation therapy; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Relaxation Therapy | Intervention Type: BEHAVIORAL; Name: Interpersonal Psychotherapy; Assigned to Arm(s): 1 Interpersonal Psychotherapy (IPT) | Intervention Type: BEHAVIORAL; Name: Prolonged Exposure Therapy; Assigned to Arm(s): 2 Prolonged Exposure (PE) | Intervention Type: BEHAVIORAL; Name: Relaxation Therapy; Assigned to Arm(s): 3 Relaxation therapy
B: Arm Label: BF-CBT and group physiotherapy; Type: EXPERIMENTAL; Interventions: Behavioral: BF-CBT and group physiotherapy | Arm Label: Waiting list; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: BF-CBT and group physiotherapy | Intervention Type: BEHAVIORAL; Name: BF-CBT and group physiotherapy; Assigned to Arm(s): BF-CBT and group physiotherapy, Waiting list
C: Arm Label: TF-CBT; Type: EXPERIMENTAL; Interventions: Behavioral: TF-CBT | Arm Label: Waiting List control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: TF-CBT; Assigned to Arm(s): TF-CBT
D: Arm Label: Waitlist+EducAid; Type: ACTIVE_COMPARATOR; Interventions: Other: EducAid educational programming | Arm Label: Waitlist; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: YRI only; Type: EXPERIMENTAL; Interventions: Behavioral: YRI, Other: EducAid educational programming | Arm Label: YRI+EducAid; Type: EXPERIMENTAL; Interventions: Behavioral: YRI, Other: EducAid educational programming | Intervention Type: BEHAVIORAL; Name: YRI; Assigned to Arm(s): YRI only, YRI+EducAid | Intervention Type: OTHER; Name: EducAid educational programming; Assigned to Arm(s): Waitlist+EducAid, YRI only, YRI+EducAid

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effectiveness of Combined Intervention Approaches in the Treatment of Affective Disorders and Chronic Pain in Victims of Torture and Massive Violence in Kosovo: A Randomized Controlled Trial
Brief Summary: This study will measure the effects of biofeedback supported cognitive behavioral therapy (BF-CBT) and group physiotherapy intervention in victims of torture and massive violence in Kosovo. The investigators aim to restore physical and psychosocial functioning of the victims of torture and massive violence with available rehabilitation practice and integrate them into the community. It is also our objective to build local knowledge and expertise to apply measurement principles and CBT methods in the Balkan region.


Options:
A: Arm Label: BF-CBT and group physiotherapy; Type: EXPERIMENTAL; Interventions: Behavioral: BF-CBT and group physiotherapy | Arm Label: Waiting list; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: BF-CBT and group physiotherapy | Intervention Type: BEHAVIORAL; Name: BF-CBT and group physiotherapy; Assigned to Arm(s): BF-CBT and group physiotherapy, Waiting list
B: Arm Label: Components-Based Interventions (CBI); Type: EXPERIMENTAL; Interventions: Other: Components-Based Intervention | Arm Label: Cognitive Processing Therapy; Type: EXPERIMENTAL; Interventions: Other: Cognitive Processing Therapy | Arm Label: Wait List Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Cognitive Processing Therapy; Assigned to Arm(s): Cognitive Processing Therapy | Intervention Type: OTHER; Name: Components-Based Intervention; Assigned to Arm(s): Components-Based Interventions (CBI)
C: Arm Label: Cognitive Processing Therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive Processing Therapy | Arm Label: Behavioral Activation; Type: EXPERIMENTAL; Interventions: Behavioral: Behavioral Activation | Arm Label: non-specific counseling; Type: EXPERIMENTAL; Interventions: Behavioral: nonspecific counseling | Arm Label: wait control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Cognitive Processing Therapy; Assigned to Arm(s): Cognitive Processing Therapy | Intervention Type: BEHAVIORAL; Name: Behavioral Activation; Assigned to Arm(s): Behavioral Activation | Intervention Type: BEHAVIORAL; Name: nonspecific counseling; Assigned to Arm(s): non-specific counseling
D: Arm Label: A; Type: EXPERIMENTAL; Interventions: Behavioral: NET | Arm Label: B; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: NET; Assigned to Arm(s): A

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effectiveness of Combined Intervention Approaches in the Treatment of Affective Disorders and Chronic Pain in Victims of Torture and Massive Violence in Kosovo: A Randomized Controlled Trial
Brief Summary: This study will measure the effects of biofeedback supported cognitive behavioral therapy (BF-CBT) and group physiotherapy intervention in victims of torture and massive violence in Kosovo. The investigators aim to restore physical and psychosocial functioning of the victims of torture and massive violence with available rehabilitation practice and integrate them into the community. It is also our objective to build local knowledge and expertise to apply measurement principles and CBT methods in the Balkan region.


Options:
A: Arm Label: Early Childhood Development Program; Type: EXPERIMENTAL; Interventions: Behavioral: Early Childhood Development Program | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Early Childhood Development Program; Assigned to Arm(s): Early Childhood Development Program
B: Arm Label: Family-Focused Psychosocial Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Family-Focused, Community-Based, Resilience-Targetting Psychosocial Intervention | Arm Label: Waiting List Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Family-Focused, Community-Based, Resilience-Targetting Psychosocial Intervention; Assigned to Arm(s): Family-Focused Psychosocial Intervention
C: Arm Label: BF-CBT and group physiotherapy; Type: EXPERIMENTAL; Interventions: Behavioral: BF-CBT and group physiotherapy | Arm Label: Waiting list; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: BF-CBT and group physiotherapy | Intervention Type: BEHAVIORAL; Name: BF-CBT and group physiotherapy; Assigned to Arm(s): BF-CBT and group physiotherapy, Waiting list
D: Arm Label: Group problem management plus; Type: EXPERIMENTAL; Interventions: Behavioral: Group problem management plus | Arm Label: Enhanced treatment as usual; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Group problem management plus, Behavioral: Enhanced treatment as usual | Intervention Type: BEHAVIORAL; Name: Group problem management plus; Assigned to Arm(s): Enhanced treatment as usual, Group problem management plus | Intervention Type: BEHAVIORAL; Name: Enhanced treatment as usual; Assigned to Arm(s): Enhanced treatment as usual

Answer: C